NCT03437642

Brief Summary

Psychological processes play a complex role in the pathophysiology of many diseases. However, the body and emotional perception of patients and the relationship between dreams and disease still need to be investigated. The investigators planned an observational and controlled research aimed at assessing some previously unaddressed baseline psychological characteristics and their changes at 1 and 5 years after a short-term psychotherapy in carefully characterised patients with heart or oncologic diseases . The patients that will be enrolled are:

  • 50 patients ≤ 75 year old with acute myocardial infarction;
  • 30 patients ≤ 75 year old with Tako-Tsubo syndrome;
  • 50 women ≤ 75 year old, recently operated on breast cancer:
  • 90 control subjects of the same age and gender of the enrolled patients, without relevant pathologies during the last 10 years. Relevant pathologies are defined as those that required a hospitalisation or a long-lasting medical therapy. At the enrolment all the subjects will undergo a complete medical evaluation, and the following psychometric tests: Self-evaluation test, Social Support Questionnaire, Beck Depression Inventory II (BDI II), MacNew Heart Disease Health-Related Quality of Life Questionnaire, State-Trait Anxiety Inventory (STAI), State-Trait Anger Expression Inventory (STAXI 2). In two distinct following meetings, an open questionnaire exploring the body and emotional perception, and another exploring past and recent dreams, will be administered. The same evaluation will be done for the healthy subjects. After the initial evaluation, all the patients will be given the choice to start a short-term psychotherapy lasting 6 months on top of medical therapy or to continue classic medical therapy only. Healthy subjects will be not offered the possibility to follow psychotherapy. At first year of follow-up, the battery of psychometric test, and the two questionnaires exploring the body and emotional perception, and changes and characteristics of dreams during the psychotherapy, will be re-administered. The following data will be evaluated: Psychological characteristics at follow-up. Incidence of new relevant medical events Quality of life Relationship between psychological characteristics and health status, and quality of life At 5 year follow-up psychometric tests and the clinical data will be evaluated in all the groups.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
220

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 19, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

March 27, 2018

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

September 18, 2019

Status Verified

September 1, 2019

Enrollment Period

4.7 years

First QC Date

December 22, 2017

Last Update Submit

September 17, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cumulative incidence of new relevant medical events

    Relevant medical events are defined as any new medical condition significantly impairing normal daily activities or requiring hospitalization or needing specific and permanent drug treatment.

    at 1 year

Secondary Outcomes (16)

  • Cumulative incidence of new relevant medical events

    at 5 years

  • Changes in body perception and dreams

    at 1 year

  • Incidence of rehospitalisations

    at 1 year

  • Incidence of rehospitalisations

    at 5 years

  • Distress grade

    at 1 year

  • +11 more secondary outcomes

Study Arms (7)

Tako-Tsubo - STP

Short term psychotherapy + Classic cardiological therapy

Behavioral: Short Term Psychotherapy

Tako-Tsubo - Control

Classic cardiological therapy only

Oncologic - STP

Short term psychotherapy + Classic oncological therapy

Behavioral: Short Term Psychotherapy

Oncologic - Control

Classic oncological therapy only

AMI - STP

Short term psychotherapy + Classic cardiological therapy

Behavioral: Short Term Psychotherapy

AMI - Control

Classic cardiological therapy only

Healthy Subjects

No therapy

Interventions

Humanistic-existential psychotherapy derived from ontopsychological method and specifically adapted to public health systems. Individual and group sessions to be tailored to individual needs

AMI - STPOncologic - STPTako-Tsubo - STP

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* 50 patients ≤ 75 year old with acute myocardial infarction; * 30 patients ≤ 75 year old with Tako-Tsubo syndrome; * 50 women ≤ 75 year old, recently operated on breast cancer: * 90 control subjects of the same age and gender of the enrolled patients, without relevant pathologies during the last 10 years. Relevant pathologies are defined as those that required a hospitalisation or a long-lasting medical therapy.

You may qualify if:

  • Patients within one week from an Acute myocardial infarction treated with primary or urgent PCI
  • Patients within one week from the onset of Tako Tsubo cardiomyopathy.
  • Patients with a diagnosis of breast cancer in the preceding six months
  • Age and sex matched control subjects without relevant medical pathologies in the preceding 10 years

You may not qualify if:

  • Cognitive impairment
  • Refusing the enrolment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San Filippo Neri General Hospital

Roma, 00135, Italy

RECRUITING

Related Publications (1)

  • Roncella A, Pristipino C, Di Carlo O, Ansuini M, Corbosiero A, Di Fusco SA, Palumbo G, Gigantesco A, Mirabella F, De Angelis R, Pasceri V, Cancellara L, Colivicchi F, Allan R, Mirri MA, Speciale G. PSYChosomatic Medicine in ONcologIc and Cardiac Disease (PSYCHONIC) Study-A Retrospective and Prospective Observational Research Protocol. J Clin Med. 2021 Dec 10;10(24):5786. doi: 10.3390/jcm10245786.

MeSH Terms

Conditions

Takotsubo CardiomyopathyBreast Neoplasms

Interventions

Psychotherapy, Brief

Condition Hierarchy (Ancestors)

CardiomyopathiesHeart DiseasesCardiovascular DiseasesVentricular Dysfunction, LeftVentricular DysfunctionNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Adriana Roncella, MD

    San Filippo Neri General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Head of Research and Training section, Interventional Cardiology Unit

Study Record Dates

First Submitted

December 22, 2017

First Posted

February 19, 2018

Study Start

March 27, 2018

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

September 18, 2019

Record last verified: 2019-09

Locations